0 XP   0   0   0

ASTEC LIFESCIENCES LIMITED
Buy, Hold or Sell?

Should you buy, hold or sell ASTEC LIFESCIENCES LIMITED?

I guess you are interested in ASTEC LIFESCIENCES LIMITED. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse ASTEC LIFESCIENCES LIMITED

Let's start. I'm going to help you getting a better view of ASTEC LIFESCIENCES LIMITED. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is ASTEC LIFESCIENCES LIMITED even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how ASTEC LIFESCIENCES LIMITED is doing in the market. If the company is worth buying. The latest step is to find out how other investors value ASTEC LIFESCIENCES LIMITED. The closing price on 2023-01-27 was INR1,545 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
ASTEC LIFESCIENCES LIMITED Daily Candlestick Chart
ASTEC LIFESCIENCES LIMITED Daily Candlestick Chart
Summary









1. Valuation of ASTEC LIFESCIENCES LIMITED




Current price per share

INR1,544.80

2. Growth of ASTEC LIFESCIENCES LIMITED




Is ASTEC LIFESCIENCES LIMITED growing?

Current yearPrevious yearGrowGrow %
How rich?$48.7m$38m$10.7m22.0%

How much money is ASTEC LIFESCIENCES LIMITED making?

Current yearPrevious yearGrowGrow %
Making money$11m$8m$3m27.6%
Net Profit Margin13.3%11.7%--

How much money comes from the company's main activities?

3. Financial Health of ASTEC LIFESCIENCES LIMITED




Comparing to competitors in the industry




  Industry Rankings ()  



Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

1.1. Profitability of ASTEC LIFESCIENCES LIMITED.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit ASTEC LIFESCIENCES LIMITED earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare ASTEC LIFESCIENCES LIMITED to the  industry mean.
  • A Net Profit Margin of 13.3% means that ₹0.13 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of ASTEC LIFESCIENCES LIMITED:

  • The MRQ is 13.3%. The company is making a huge profit. +2
  • The TTM is 13.3%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ13.3%TTM13.3%0.0%
TTM13.3%YOY11.7%+1.6%
TTM13.3%5Y10.4%+2.9%
5Y10.4%10Y9.7%+0.7%
1.1.2. Return on Assets

Shows how efficient ASTEC LIFESCIENCES LIMITED is using its assets to generate profit.

  • Above 5% is considered healthy but always compare ASTEC LIFESCIENCES LIMITED to the  industry mean.
  • 10.0% Return on Assets means that ASTEC LIFESCIENCES LIMITED generated ₹0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of ASTEC LIFESCIENCES LIMITED:

  • The MRQ is 10.0%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 10.0%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ10.0%TTM10.0%0.0%
TTM10.0%YOY9.6%+0.4%
TTM10.0%5Y8.8%+1.2%
5Y8.8%10Y8.3%+0.5%
1.1.3. Return on Equity

Shows how efficient ASTEC LIFESCIENCES LIMITED is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare ASTEC LIFESCIENCES LIMITED to the  industry mean.
  • 22.7% Return on Equity means ASTEC LIFESCIENCES LIMITED generated ₹0.23 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of ASTEC LIFESCIENCES LIMITED:

  • The MRQ is 22.7%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 22.7%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ22.7%TTM22.7%0.0%
TTM22.7%YOY21.0%+1.6%
TTM22.7%5Y20.2%+2.4%
5Y20.2%10Y19.2%+1.1%

1.2. Operating Efficiency of ASTEC LIFESCIENCES LIMITED.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient ASTEC LIFESCIENCES LIMITED is operating .

  • Measures how much profit ASTEC LIFESCIENCES LIMITED makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare ASTEC LIFESCIENCES LIMITED to the  industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of ASTEC LIFESCIENCES LIMITED:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y8.7%-8.7%
5Y8.7%10Y10.0%-1.2%
1.2.2. Operating Ratio

Measures how efficient ASTEC LIFESCIENCES LIMITED is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 1.47 means that the operating costs are ₹1.47 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of ASTEC LIFESCIENCES LIMITED:

  • The MRQ is 1.472. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.472. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.472TTM1.4720.000
TTM1.472YOY1.517-0.045
TTM1.4725Y1.367+0.105
5Y1.36710Y1.253+0.114

1.3. Liquidity of ASTEC LIFESCIENCES LIMITED.

1.3. Liquidity
1.3.1. Current Ratio

Measures if ASTEC LIFESCIENCES LIMITED is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 1.05 means the company has ₹1.05 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of ASTEC LIFESCIENCES LIMITED:

  • The MRQ is 1.051. The company is just able to pay all its short-term debts.
  • The TTM is 1.051. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.051TTM1.0510.000
TTM1.051YOY1.025+0.026
TTM1.0515Y1.018+0.033
5Y1.01810Y1.019-0.001
1.3.2. Quick Ratio

Measures if ASTEC LIFESCIENCES LIMITED is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare ASTEC LIFESCIENCES LIMITED to the  industry mean.
  • A Quick Ratio of 0.56 means the company can pay off ₹0.56 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of ASTEC LIFESCIENCES LIMITED:

  • The MRQ is 0.559. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.559. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.559TTM0.5590.000
TTM0.559YOY0.583-0.024
TTM0.5595Y0.552+0.007
5Y0.55210Y0.560-0.008

1.4. Solvency of ASTEC LIFESCIENCES LIMITED.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of ASTEC LIFESCIENCES LIMITED assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare ASTEC LIFESCIENCES LIMITED to industry mean.
  • A Debt to Asset Ratio of 0.56 means that ASTEC LIFESCIENCES LIMITED assets are financed with 55.8% credit (debt) and the remaining percentage (100% - 55.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of ASTEC LIFESCIENCES LIMITED:

  • The MRQ is 0.558. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.558. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.558TTM0.5580.000
TTM0.558YOY0.544+0.014
TTM0.5585Y0.564-0.006
5Y0.56410Y0.568-0.004
1.4.2. Debt to Equity Ratio

Measures if ASTEC LIFESCIENCES LIMITED is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare ASTEC LIFESCIENCES LIMITED to the  industry mean.
  • A Debt to Equity ratio of 126.2% means that company has ₹1.26 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of ASTEC LIFESCIENCES LIMITED:

  • The MRQ is 1.262. The company is able to pay all its debts with equity. +1
  • The TTM is 1.262. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.262TTM1.2620.000
TTM1.262YOY1.192+0.070
TTM1.2625Y1.297-0.035
5Y1.29710Y1.317-0.020

2. Market Valuation of ASTEC LIFESCIENCES LIMITED

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings ASTEC LIFESCIENCES LIMITED generates.

  • Above 15 is considered overpriced but always compare ASTEC LIFESCIENCES LIMITED to the  industry mean.
  • A PE ratio of 31.28 means the investor is paying ₹31.28 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of ASTEC LIFESCIENCES LIMITED:

  • The EOD is 33.691. Good. +1
  • The MRQ is 31.279. Good. +1
  • The TTM is 31.279. Good. +1
Trends
Current periodCompared to+/- 
EOD33.691MRQ31.279+2.412
MRQ31.279TTM31.2790.000
TTM31.279YOY38.808-7.529
TTM31.2795Y29.699+1.580
5Y29.69910Y35.270-5.572
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of ASTEC LIFESCIENCES LIMITED.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of ASTEC LIFESCIENCES LIMITED:

  • The MRQ is 22.654. Seems overpriced? -1
  • The TTM is 22.654. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ22.654TTM22.6540.000
TTM22.654YOY28.373-5.719
TTM22.6545Y22.060+0.595
5Y22.06010Y22.0600.000

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of ASTEC LIFESCIENCES LIMITED is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of 7.09 means the investor is paying ₹7.09 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of ASTEC LIFESCIENCES LIMITED:

  • The EOD is 7.635. Seems overpriced? -1
  • The MRQ is 7.089. Seems overpriced? -1
  • The TTM is 7.089. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD7.635MRQ7.089+0.547
MRQ7.089TTM7.0890.000
TTM7.089YOY8.165-1.076
TTM7.0895Y6.059+1.030
5Y6.05910Y6.506-0.448
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of ASTEC LIFESCIENCES LIMITED compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--44.47544.4750%31.842+40%26.317+69%33.720+32%
Book Value Growth--1.2821.2820%1.254+2%1.235+4%1.235+4%
Book Value Per Share--202.319202.3190%157.844+28%135.320+50%124.556+62%
Book Value Per Share Growth--1.2821.2820%1.253+2%1.234+4%1.234+4%
Current Ratio--1.0511.0510%1.025+3%1.018+3%1.019+3%
Debt To Asset Ratio--0.5580.5580%0.544+3%0.564-1%0.568-2%
Debt To Equity Ratio--1.2621.2620%1.192+6%1.297-3%1.317-4%
Dividend Per Share--1.4991.4990%1.499+0%1.4990%1.4990%
Dividend Per Share Growth--1.0001.0000%1.000+0%1.000+0%1.000+0%
Eps--45.85245.8520%33.209+38%27.898+64%24.882+84%
Eps Growth--1.3811.3810%1.368+1%1.3850%1.3850%
Free Cash Flow Per Share---41.012-41.0120%-56.510+38%-9.219-78%-7.824-81%
Free Cash Flow Per Share Growth--1.2741.2740%-0.898+170%2.839-55%2.839-55%
Free Cash Flow To Equity Per Share--0.0530.0530%-14.986+28531%-0.437+929%-0.586+1212%
Free Cash Flow To Equity Per Share Growth--2.0042.0040%-1.025+151%15.596-87%15.596-87%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---2403.144--------
Intrinsic Value_10Y_min---1994.465--------
Intrinsic Value_1Y_max---84.277--------
Intrinsic Value_1Y_min---81.892--------
Intrinsic Value_3Y_max---372.516--------
Intrinsic Value_3Y_min---349.683--------
Intrinsic Value_5Y_max---804.583--------
Intrinsic Value_5Y_min---728.999--------
Net Profit Margin--0.1330.1330%0.117+13%0.104+28%0.097+38%
Operating Margin----0%-0%0.087-100%0.100-100%
Operating Ratio--1.4721.4720%1.517-3%1.367+8%1.253+17%
Pb Ratio7.635+7%7.0897.0890%8.165-13%6.059+17%6.506+9%
Pe Ratio33.691+7%31.27931.2790%38.808-19%29.699+5%35.270-11%
Peg Ratio--22.65422.6540%28.373-20%22.060+3%22.060+3%
Price Per Share1544.800+7%1434.2001434.2000%1288.800+11%851.220+68%812.433+77%
Price To Total Gains Ratio33.602+7%31.19631.1960%38.656-19%29.815+5%26.273+19%
Profit Growth--1.3811.3810%1.369+1%1.3860%1.3860%
Quick Ratio--0.5590.5590%0.583-4%0.552+1%0.5600%
Return On Assets--0.1000.1000%0.096+4%0.088+14%0.083+21%
Return On Equity--0.2270.2270%0.210+8%0.202+12%0.192+18%
Revenue Growth--1.2191.2190%1.062+15%1.168+4%1.168+4%
Total Gains Per Share--45.97445.9740%33.341+38%27.816+65%35.219+31%
Total Gains Per Share Growth--1.3791.3790%1.393-1%1.073+29%1.073+29%
Usd Book Value--48768934.20048768934.2000%38028906.300+28%32579649.600+50%29979154.900+63%
Usd Book Value Change Per Share--0.5470.5470%0.392+40%0.324+69%0.415+32%
Usd Book Value Per Share--2.4892.4890%1.941+28%1.664+50%1.532+62%
Usd Dividend Per Share--0.0180.0180%0.018+0%0.0180%0.0180%
Usd Eps--0.5640.5640%0.408+38%0.343+64%0.306+84%
Usd Free Cash Flow---9886026.600-9886026.6000%-13614882.300+38%-2593026.960-74%-2160855.800-78%
Usd Free Cash Flow Per Share---0.504-0.5040%-0.695+38%-0.113-78%-0.096-81%
Usd Free Cash Flow To Equity Per Share--0.0010.0010%-0.184+28531%-0.005+929%-0.007+1212%
Usd Price Per Share19.001+7%17.64117.6410%15.852+11%10.470+68%9.993+77%
Usd Profit--11052607.80011052607.8000%8001014.700+38%6717261.240+65%5989630.550+85%
Usd Revenue--83217630.30083217630.3000%68249268.300+22%62872451.220+32%58818481.100+41%
Usd Total Gains Per Share--0.5650.5650%0.410+38%0.342+65%0.433+31%
 EOD+2 -3MRQTTM+0 -0YOY+35 -65Y+27 -1510Y+27 -15

3.2. Fundamental Score

Let's check the fundamental score of ASTEC LIFESCIENCES LIMITED based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1533.691
Price to Book Ratio (EOD)Between0-17.635
Net Profit Margin (MRQ)Greater than00.133
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.559
Current Ratio (MRQ)Greater than11.051
Debt to Asset Ratio (MRQ)Less than10.558
Debt to Equity Ratio (MRQ)Less than11.262
Return on Equity (MRQ)Greater than0.150.227
Return on Assets (MRQ)Greater than0.050.100
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of ASTEC LIFESCIENCES LIMITED based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5032.765
Ma 20Greater thanMa 501,671.333
Ma 50Greater thanMa 1001,806.304
Ma 100Greater thanMa 2001,914.283
OpenGreater thanClose1,618.450
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2021-12-31. Currency in INR. All numbers in thousands.

Summary
Total Assets8,967,567
Total Liabilities5,002,613
Total Stockholder Equity3,964,954
 As reported
Total Liabilities 5,002,613
Total Stockholder Equity+ 3,964,954
Total Assets = 8,967,567

Assets

Total Assets8,967,567
Total Current Assets5,156,772
Long-term Assets5,156,772
Total Current Assets
Cash And Cash Equivalents 5,545
Short-term Investments 285
Net Receivables 2,736,276
Inventory 1,911,450
Other Current Assets 63,640
Total Current Assets  (as reported)5,156,772
Total Current Assets  (calculated)4,717,196
+/- 439,576
Long-term Assets
Property Plant Equipment 3,513,790
Intangible Assets 113,904
Long-term Assets Other 129,815
Long-term Assets  (as reported)3,810,795
Long-term Assets  (calculated)3,757,509
+/- 53,286

Liabilities & Shareholders' Equity

Total Current Liabilities4,905,881
Long-term Liabilities95,100
Total Stockholder Equity3,964,954
Total Current Liabilities
Short-term Debt 2,393,731
Short Long Term Debt 2,793,731
Accounts payable 1,898,276
Other Current Liabilities 11,135
Total Current Liabilities  (as reported)4,905,881
Total Current Liabilities  (calculated)7,096,873
+/- 2,190,992
Long-term Liabilities
Long-term Liabilities  (as reported)95,100
Long-term Liabilities  (calculated)0
+/- 95,100
Total Stockholder Equity
Common Stock195,976
Retained Earnings 3,162,462
Capital Surplus 603,480
Other Stockholders Equity 115
Total Stockholder Equity (as reported)3,964,954
Total Stockholder Equity (calculated)3,962,033
+/- 2,921
Other
Capital Stock195,976
Cash and Short Term Investments 5,830
Common Stock Shares Outstanding 19,598
Liabilities and Stockholders Equity 8,967,567
Net Debt 2,788,186
Net Invested Capital 6,758,685
Net Working Capital 250,891



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
3,335,901
4,131,837
4,610,821
5,717,184
6,775,859
8,967,567
8,967,5676,775,8595,717,1844,610,8214,131,8373,335,901
   > Total Current Assets 
1,983,730
2,316,791
2,484,776
3,317,512
3,304,304
5,156,772
5,156,7723,304,3043,317,5122,484,7762,316,7911,983,730
       Cash And Cash Equivalents 
13,879
3,312
2,123
3,081
3,388
5,545
5,5453,3883,0812,1233,31213,879
       Short-term Investments 
5,608
243
169
1,942
2,536
285
2852,5361,9421692435,608
       Net Receivables 
1,113,040
1,237,759
1,221,212
1,920,318
1,871,531
2,736,276
2,736,2761,871,5311,920,3181,221,2121,237,7591,113,040
       Inventory 
655,514
784,783
928,495
1,211,706
1,071,732
1,911,450
1,911,4501,071,7321,211,706928,495784,783655,514
       Other Current Assets 
180,691
286,445
313,078
165,560
24,486
63,640
63,64024,486165,560313,078286,445180,691
   > Long-term Assets 
0
0
2,126,045
2,399,672
3,471,555
3,810,795
3,810,7953,471,5552,399,6722,126,04500
       Property Plant Equipment 
1,069,861
1,540,809
1,835,147
2,141,679
3,232,257
3,513,790
3,513,7903,232,2572,141,6791,835,1471,540,8091,069,861
       Intangible Assets 
35,091
28,589
24,145
35,638
51,627
113,904
113,90451,62735,63824,14528,58935,091
       Long-term Assets Other 
0
0
54
116,513
1
129,815
129,8151116,5135400
> Total Liabilities 
1,955,683
2,435,335
2,585,956
3,251,526
3,684,078
5,002,613
5,002,6133,684,0783,251,5262,585,9562,435,3351,955,683
   > Total Current Liabilities 
1,937,229
2,383,878
2,488,043
3,183,629
3,222,765
4,905,881
4,905,8813,222,7653,183,6292,488,0432,383,8781,937,229
       Short-term Debt 
1,259,988
1,241,728
1,756,679
987,116
1,470,310
2,393,731
2,393,7311,470,310987,1161,756,6791,241,7281,259,988
       Short Long Term Debt 
0
0
1,756,679
987,115
1,471,991
2,793,731
2,793,7311,471,991987,1151,756,67900
       Accounts payable 
570,706
999,300
632,544
2,023,896
1,248,149
1,898,276
1,898,2761,248,1492,023,896632,544999,300570,706
       Other Current Liabilities 
100,677
136,158
93,097
162,110
8,440
11,135
11,1358,440162,11093,097136,158100,677
   > Long-term Liabilities 
0
0
94,788
64,612
459,921
95,100
95,100459,92164,61294,78800
       Long term Debt Total 
4,019
2,488
0
0
400,000
0
0400,000002,4884,019
> Total Stockholder Equity
1,380,218
1,696,502
2,024,865
2,465,658
3,091,781
3,964,954
3,964,9543,091,7812,465,6582,024,8651,696,5021,380,218
   Common Stock
195,129
195,277
195,527
195,684
195,876
195,976
195,976195,876195,684195,527195,277195,129
   Retained Earnings 
601,502
914,392
1,235,979
1,673,906
2,293,308
3,162,462
3,162,4622,293,3081,673,9061,235,979914,392601,502
   Capital Surplus 
0
580,231
585,500
589,164
598,314
603,480
603,480598,314589,164585,500580,2310
   Treasury Stock000000
   Other Stockholders Equity 
7,009
6,622
7,869
6,904
133
115
1151336,9047,8696,6227,009



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue6,765,661
Cost of Revenue-4,397,118
Gross Profit2,368,5432,368,543
 
Operating Income (+$)
Gross Profit2,368,543
Operating Expense-5,559,817
Operating Income1,197,157-3,191,274
 
Operating Expense (+$)
Research Development9,140
Selling General Administrative731,291
Selling And Marketing Expenses-
Operating Expense5,559,817740,431
 
Net Interest Income (+$)
Interest Income11,865
Interest Expense-90,577
Net Interest Income-87,946-78,712
 
Pretax Income (+$)
Operating Income1,197,157
Net Interest Income-87,946
Other Non-Operating Income Expenses-
Income Before Tax (EBT)1,211,2581,197,157
EBIT - interestExpense = -90,577
898,586
989,163
Interest Expense90,577
Earnings Before Interest and Taxes (ebit)-1,301,835
Earnings Before Interest and Taxes (ebitda)1,645,398
 
After tax Income (+$)
Income Before Tax1,211,258
Tax Provision-312,432
Net Income From Continuing Ops898,826898,826
Net Income898,586
Net Income Applicable To Common Shares898,586
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-87,946
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
NGU24-NYM.COMM
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NGU24-NYM.COMM.

NGU24-NYM.COMM Daily Candlestick Chart
NGM24-NYM.COMM
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NGM24-NYM.COMM.

NGM24-NYM.COMM Daily Candlestick Chart
NGQ24-NYM.COMM
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NGQ24-NYM.COMM.

NGQ24-NYM.COMM Daily Candlestick Chart
ISKJ.MCX
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ISKJ.MCX.

ISKJ.MCX Daily Candlestick Chart
CHKZ.MCX
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CHKZ.MCX.

CHKZ.MCX Daily Candlestick Chart
VSYD.MCX
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VSYD.MCX.

VSYD.MCX Daily Candlestick Chart
VRSB.MCX
5 hours ago

I found you a Golden Cross on the daily chart of VRSB.MCX.

VRSB.MCX Daily Candlestick Chart
TBRU.MCX
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TBRU.MCX.

TBRU.MCX Daily Candlestick Chart
SNGSP.MCX
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SNGSP.MCX.

SNGSP.MCX Daily Candlestick Chart
RBCM.MCX
5 hours ago

I found you a Golden Cross on the daily chart of RBCM.MCX.

RBCM.MCX Daily Candlestick Chart
OKEY.MCX
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of OKEY.MCX.

OKEY.MCX Daily Candlestick Chart
MTLR.MCX
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MTLR.MCX.

MTLR.MCX Daily Candlestick Chart
MRKZ.MCX
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MRKZ.MCX.

MRKZ.MCX Daily Candlestick Chart
KRKN.MCX
5 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of KRKN.MCX.

KRKN.MCX Daily Candlestick Chart
JNOS.MCX
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of JNOS.MCX.

JNOS.MCX Daily Candlestick Chart
BLNG.MCX
5 hours ago

I found you a Golden Cross on the daily chart of BLNG.MCX.

BLNG.MCX Daily Candlestick Chart
ASSB.MCX
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ASSB.MCX.

ASSB.MCX Daily Candlestick Chart
CSYZ.MU
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CSYZ.MU.

CSYZ.MU Daily Candlestick Chart
MOH.MU
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MOH.MU.

MOH.MU Daily Candlestick Chart
TBK.V
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TBK.V.

TBK.V Daily Candlestick Chart
UMDK.F
6 hours ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of UMDK.F.

UMDK.F Daily Candlestick Chart
RY4C.BE
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of RY4C.BE.

RY4C.BE Daily Candlestick Chart
PLY.BE
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of PLY.BE.

PLY.BE Daily Candlestick Chart
PDL.LSE
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of PDL.LSE.

PDL.LSE Daily Candlestick Chart
27F0.MU
6 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of 27F0.MU.

27F0.MU Daily Candlestick Chart